NEW YORK, Jan. 27, 2012 /PRNewswire/ -- Momenta
Pharmaceuticals, Inc. (NASD: MNTA) will replace HealthSpring, Inc.
(NYSE: HS) in the S&P SmallCap 600 index after the close of
trading on Tuesday, January 31.
S&P 500 constituent Cigna Corp. (NYSE: CI) is acquiring
HealthSpring in a deal expected to be completed on January 30, pending final approvals.
Momenta Pharmaceuticals is a biotechnology company specializing
in the characterization and process engineering of complex
molecules. Headquartered in Cambridge,
MA, the company will be added to the S&P SmallCap 600
GICS (Global Industry Classification Standard) Biotechnology
Sub-Industry index.
Following is a summary of the change:
S&P
SMALLCAP 600 INDEX – January 31, 2012
|
|
COMPANY
|
GICS
ECONOMIC SECTOR
|
GICS
SUB-INDUSTRY
|
ADDED
|
Momenta
Pharmaceuticals
|
Health
Care
|
Biotechnology
|
DELETED
|
HealthSpring
|
Health
Care
|
Managed
Health Care
|
About S&P Indices
S&P Indices, a leading brand of the McGraw-Hill
Companies (NYSE: MHP), maintains a wide variety of investable and
benchmark indices to meet an array of investor needs. Over
$1.45 trillion is directly indexed to
our indices, which includes the S&P 500, the world's most
followed stock market index, the S&P/Case-Shiller Home Price
Indices, the leading measure of U.S. home prices, the S&P
Global BMI, an index with approximately 11,000 constituents, the
S&P GSCI, the industry's most closely watched commodities
index, and the S&P National AMT-Free Municipal Bond Index, the
premier investable index for U.S. municipal bonds. For more
information, please visit: www.standardandpoors.com/indices.
It is not possible to invest directly in an index. S&P
Indices does not sponsor, endorse, sell, or promote any S&P
index-based investment product. This document does not constitute
an offer of services in jurisdictions where S&P Indices or its
affiliates do not have the necessary licenses. S&P Indices
receives compensation in connection with licensing its indices to
third parties.
For more information:
Dave Guarino
Communications
S&P Indices
dave_guarino@standardandpoors.com
212-438-1471
David Blitzer
Managing Director and Chairman of the Index Committee
S&P Indices
david_blitzer@standardandpoors.com
212-438-3908
SOURCE S&P Indices